Olanzapine elevation of serum creatine kinase.
Martí-Bonmatí
Ezequiel
E
San Valero-Carcelén
Eva
E
Ortega-García
María Pilar
MP
Rubini-Puig
Ricardo
R
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology; D001569:Benzodiazepines; D003402:Creatine Kinase / Q000097:blood*; D052279:Creatine Kinase, MB Form; D003937:Diagnosis, Differential; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000097:blood / Q000175:diagnosis / Q000201:enzymology; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000494:pharmacology; D013268:Stimulation, Chemical
D014150:Antipsychotic Agents; D007527:Isoenzymes; D001569:Benzodiazepines; D010890:Pirenzepine; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form; D000077152:Olanzapine